European Commission approves Novartis' Votubia to treat renal ... pharmabiz.com The European Commission (EC) has approved Novartis' Votubia (everolimus) tablets for the treatment of adult patients with renal angiomyolipoma associated with tuberous sclerosis complex (TSC) who are at risk of complications (based on factors such as ... Novartis gets another approval for everolimus in EU EC approves extra tumour indication for Novartis' Votubia Novartis Cancer Drug Gets Another EU OK |
